The center's breeding visits were successfully completed according to the protocols of the St. Petersburg Institute of Vaccines and Serums of the Federal Medical and Biological Agency of Russia: it is planned to study a new nasal vaccine against Covid-19 infection and a vaccine against hemophilic infection

Permission was obtained from the Ministry of Health to conduct a phase II study to assess the effectiveness of inhalation therapy in the treatment of patients with chronic bronchitis in the acute phase

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen